Novel process

Details for Australian Patent Application No. 2004255517 (hide)

Owner AstraZeneca AB

Inventors Rogueda, Philippe

Agent Freehills

Pub. Number AU-A-2004255517

PCT Pub. Number WO2005/004847

Priority 0302029-4 07.07.03 SE

Filing date 5 July 2004

Wipo publication date 20 January 2005

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

B01D 9/02 (2006.01) Crystallisation

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004847 Priority application(s): WO2005/004847

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255520-Dispenser with reservoir containing a drug of abuse

2004255515-Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof